Marti Goemann

1.5k total citations
6 papers, 1.1k citations indexed

About

Marti Goemann is a scholar working on Genetics, Biotechnology and Immunology. According to data from OpenAlex, Marti Goemann has authored 6 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 3 papers in Biotechnology and 3 papers in Immunology. Recurrent topics in Marti Goemann's work include Virus-based gene therapy research (4 papers), Cancer Research and Treatments (3 papers) and Immunotherapy and Immune Responses (3 papers). Marti Goemann is often cited by papers focused on Virus-based gene therapy research (4 papers), Cancer Research and Treatments (3 papers) and Immunotherapy and Immune Responses (3 papers). Marti Goemann collaborates with scholars based in United States. Marti Goemann's co-authors include Bahar Mikhak, Steven Piantadosi, Angelo M. De Marzo, Michael A. Carducci, William G. Nelson, Jonathan W. Simons, Drew M. Pardoll, Séamus O’Reilly, Daniel A. Laheru and Ross A. Abrams and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Marti Goemann

6 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marti Goemann United States	4	713	611	438	418	169	6	1.1k
Gail DeRaffele United States	12	785 1.1×	624 1.0×	336 0.8×	392 0.9×	68 0.4×	19	1.1k
Adri Recio United States	8	369 0.5×	333 0.5×	236 0.5×	276 0.7×	159 0.9×	8	796
Andressa Ardiani United States	16	447 0.6×	316 0.5×	269 0.6×	148 0.4×	104 0.6×	19	819
B. Van den Eynde Belgium	7	640 0.9×	1.4k 2.2×	499 1.1×	154 0.4×	75 0.4×	14	1.6k
Cristina Olagüe Spain	14	284 0.4×	312 0.5×	327 0.7×	273 0.7×	72 0.4×	26	821
P L Stern United Kingdom	11	413 0.6×	355 0.6×	254 0.6×	71 0.2×	62 0.4×	13	835
Lynn J. Buchanan United Kingdom	4	420 0.6×	532 0.9×	189 0.4×	178 0.4×	69 0.4×	7	801
Teresa Rasalan United States	12	742 1.0×	953 1.6×	293 0.7×	77 0.2×	59 0.3×	17	1.2k
William Shingler United Kingdom	13	380 0.5×	435 0.7×	191 0.4×	149 0.4×	24 0.1×	26	697
Franco Marincola United States	14	627 0.9×	1.1k 1.7×	385 0.9×	96 0.2×	28 0.2×	20	1.3k

Countries citing papers authored by Marti Goemann

Since Specialization

Citations

This map shows the geographic impact of Marti Goemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marti Goemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marti Goemann more than expected).

Fields of papers citing papers by Marti Goemann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marti Goemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marti Goemann. The network helps show where Marti Goemann may publish in the future.

Co-authorship network of co-authors of Marti Goemann

This figure shows the co-authorship network connecting the top 25 collaborators of Marti Goemann. A scholar is included among the top collaborators of Marti Goemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marti Goemann. Marti Goemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

DeWeese, Theodore L., H. Van der Poel, S. Li, et al.. (2001). A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy.. PubMed. 61(20). 7464–72. 299 indexed citations

Jaffee, Elizabeth M., Ralph H. Hruban, Barbara Biedrzycki, et al.. (2001). Novel Allogeneic Granulocyte-Macrophage Colony-Stimulating Factor–Secreting Tumor Vaccine for Pancreatic Cancer: A Phase I Trial of Safety and Immune Activation. Journal of Clinical Oncology. 19(1). 145–156. 457 indexed citations

DeWeese, Theodore L., Roger Drew, Marti Goemann, et al.. (2000). Results of a phase I study of CN706, a replication-competent cytolytic adenovirus, for the treatment of adenocarcinoma of the prostate which is locally-recurrent following radiation therapy. International Journal of Radiation Oncology*Biology*Physics. 48(3). 172–173. 3 indexed citations

Simons, Jonathan W., Bahar Mikhak, Angelo M. De Marzo, et al.. (1999). CLINICAL ACTIVITY AND BROKEN IMMUNOLOGIC TOLERANCE FROM EX VIVO GM-CSF GENE TRANSDUCED PROSTATE CANCER VACCINES. The Journal of Urology. 51–51. 8 indexed citations

Simons, Jonathan W., Bahar Mikhak, Angelo M. De Marzo, et al.. (1999). Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer.. PubMed. 59(20). 5160–8. 375 indexed citations

Ramakrishna, Naren, Angelo M. De Marzo, Roberto Rodriguez, et al.. (1999). 2152 Bioactivity of CN706, a PSA specific oncolytic adenoviral vector: A phase I trial of in vivo gene therapy for locally-recurrent prostate cancer following radiation therapy. International Journal of Radiation Oncology*Biology*Physics. 45(3). 356–356. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact